Fresenius Kabi USA has acquired Becton, Dickinson and Co.’s Rx business, which includes a pharmaceutical manufacturing plant in Wilson, NC, and the BD Simplist line of seven drugs in ready-to-administer prefilled glass syringes. The companies also signed a 10-year supply and distribution agreement under which Fresenius Kabi will supply BD with a portfolio of intravenous solutions. Both plan to offer a range of IV solutions in the U.S. beginning in 2016. Financial and contract terms were not ...